by Associated Press Published: November 15,2011
Tags: courts, doctors, drugs, healthcare, medication, medicines, physicians, pleas, prescriptions, surgeons
GULFPORT — The last of six alleged middlemen accused in a prescription conspiracy case involving a former Stone County surgeon selling prescriptions for pain pills and anxiety medication intends to plead guilty in the case. That’s according to U.S. District Court records. Kevin Anderson was one of six accused in a federal indictment of obtaining [...] [...]
JACKSON — Transcript Pharmacy has landed on the Inc. 5000 list of the fastest-growing privately owned businesses in America for the fourth year in a row. It ranked 116 in the health industry. “We are blessed to be trusted by so many healthcare professionals and so many patients who, month after month, give us the [...] [...]
MADISON — Hawthorn Pharmaceuticals Inc. has struck an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer’s and other neurodegenerative diseases. Under the terms of the agreement, Hawthorn will receive an exclusive worldwide license to develop and commercialize hawAD14 and will be responsible for [...] [...]
JACKSON — Mississippi Attorney General Jim Hood says the state has been awarded $38.2 million in a Medicaid drug-pricing lawsuit. Hood says a judge found that a pharmaceutical company, Sandoz Inc., inflated the average wholesale prices for its generic drugs. In a news release yesterday, Hood says the inflated number caused Mississippi Medicaid to lose [...] [...]
JACKSON — A federal lawsuit filed this week in Mississippi claims a major pharmaceutical company made millions of dollars by misrepresenting clinical data and using sham litigation to maintain a monopoly over a drug used to treat depression and anxiety. Uniondale Chemists Inc., a retail pharmacy in Uniondale, N.Y., filed the lawsuit Tuesday in U.S. [...] [...]
ACROSS MISSISSIPPI — German conglomerate Bayer CropScience has agreed to pay up to $750 million to settle several lawsuits with U.S. farmers who claimed a strain of the company’s unapproved genetically modified rice contaminated the food supply and hurt their crop prices. The litigation goes back to 2006, when Bayer disclosed that an experimental strain [...] [...]
Loading ...